BOULDER — Biopharmaceutical producer OnKure Inc. has appointed a new vice president of drug metabolism and pharmacokinetics and clinical pharmacology. Kevin Litwiler joins the cancer-therapy company with more than 30 … Continued
Source: BizWest
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
BOULDER — Biopharmaceutical company OnKure Inc. has raised nearly $54 million of a $60 million funding round, according to documents…
BOULDER — Oncology pharmaceuticals producer OnKure Inc. has hired Roberta (Robbie) Alton as its new vice president of clinical development.…
BOULDER — OnKure Inc. has entered into a collaboration with pharmaceutical giant Pfizer Inc. (NYSE: PFE) for a skin cancer…
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
